| Sustained Oral Fiber Supplementation for Patients Undergoing Donor Stem Cell Transplantation for Hematological Malignancies (NCT04829136) | Fred Hutchinson Cancer Center | 2022-06-22 |
| Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer (NCT05228275) | Children's Oncology Group | 2022-04-08 |
| Food Safety Educational Training Program to Improve Food Safety Knowledge and Behaviors in Cancer Patients Receiving Treatment (NCT06630442) | Ohio State University Comprehensive Cancer Center | 2022-02-21 |
| Two Step Haplo With Radiation Conditioning (NCT05031897) | Thomas Jefferson University | 2021-10-25 |
| Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial (NCT04320888) | National Cancer Institute (NCI) | 2021-05-03 |
| Evaluation of 3D Surface Scanning for Virtual-CT Based Radiation Therapy Treatment Planning (NCT06409000) | Mayo Clinic | 2021-01-19 |
| NCI COVID-19 in Cancer Patients, NCCAPS Study (NCT04387656) | National Cancer Institute (NCI) | 2020-06-05 |
| Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors (NCT03996265) | University of Rochester NCORP Research Base | 2019-06-27 |
| Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study (NCT06304168) | Mayo Clinic | 2019-05-13 |
| Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F) (NCT05490771) | National Cancer Institute (NCI) | 2018-06-20 |
| Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant (NCT03057054) | Children's Oncology Group | 2018-04-30 |
| Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer (NCT03223753) | Children's Oncology Group | 2017-11-29 |
| Pre-myeloid Cancer and Bone Marrow Failure Clinic Study (NCT02958462) | Mayo Clinic | 2017-01-16 |
| Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T) (NCT06357988) | National Cancer Institute (NCI) | 2016-06-20 |
| Collection and Storage of Tissue and Blood Samples From Patients With Cancer (NCT02474160) | National Cancer Institute LAO | 2015-05-19 |